Literature DB >> 6510472

Characteristics of the binding of platelet-activating factor to platelets of different animal species.

P Iñarrea, J Gomez-Cambronero, M Nieto, M S Crespo.   

Abstract

The binding of platelet-activating factor (PAF-acether) to human, rabbit and rat platelets was investigated by incubating washed platelets at 37 degrees C with radiolabeled [3H]PAF-acether. Scatchard plot analysis of the binding showed that human and rabbit platelets possess two different types of binding sites. One of them was saturable and of high affinity (KD 1.58 +/- 0.36 nM in human and 0.9 +/- 0.5 nM in rabbits), and the other one had nearly infinite binding capacity. By contrast, rat platelets only showed non-specific binding. Addition of unlabeled PAF-acether 5 min after the addition of [3H]PAF-acether showed that internalization of 66 +/- 9% of the specific binding in human and 52 +/- 6.9% in rabbit platelets had occurred. Specific binding of [3H]PAF-acether in rabbit platelets correlated well with [3H]serotonin release in response to different doses of PAF-acether and with the uptake of calcium by the platelets. By contrast, PAF-acether did not induce [3H]serotonin release or calcium uptake by rat platelets. The following data suggest that the potential of PAF-acether to activate platelets depends on the interaction with a specific membrane receptor rather than on a non-receptor-mediated alteration of the platelet membrane: (1) platelets from animal species sensitive to PAF-acether show saturability and specificity of binding; (2) platelets from one animal species non-sensitive to PAF-acether lack specific binding; (3) PAF-acether does not induce calcium uptake by platelets from an animal species which lacks specific binding sites.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6510472     DOI: 10.1016/0014-2999(84)90623-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  21 in total

1.  Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.

Authors:  M T Domingo; F Piro; C Broquet; E Auclair; P E Chabrier; P Braquet
Journal:  Lipids       Date:  1992-08       Impact factor: 1.880

Review 2.  Leucocyte/endothelium interactions and microvessel permeability: coupled or uncoupled?

Authors:  Pingnian He
Journal:  Cardiovasc Res       Date:  2010-05-13       Impact factor: 10.787

3.  Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration.

Authors:  J L Wallace; B J Whittle
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

4.  Guinea pig bone marrow cells treated with platelet-activating factor generate factor(s) which affects their DNA synthesis and microbicidal activity.

Authors:  I Kudo; T Kato; H Hayashi; R Yanoshita; K Ikizawa; H Uda; K Inoue
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

5.  Nutritional prevention on hypertension, cerebral hemodynamics and thrombosis in stroke-prone spontaneously hypertensive rats.

Authors:  Takanori Noguchi; Katsumi Ikeda; Yasuto Sasaki; Yukio Yamori
Journal:  Cell Mol Neurobiol       Date:  2004-10       Impact factor: 5.046

6.  Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked.

Authors:  L Touqui; M Hatmi; B B Vargaftig
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

7.  1-O-alkyl-2-acetyl-sn-glycerol: a platelet-activating factor metabolite with biological activity in vascular smooth muscle cells.

Authors:  L L Stoll; P H Figard; N R Yerram; M A Yorek; A A Spector
Journal:  Cell Regul       Date:  1989-11

8.  Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.

Authors:  M G Sirois; W T de Lima; A J de Brum Fernandes; R J Johnson; G E Plante; P Sirois
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

9.  Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation.

Authors:  W Zhou; B A Levine; M S Olson
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock.

Authors:  M Giral; D Balsa; R Ferrando; M Merlos; J Garcia-Rafanell; J Forn
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.